This essay discusses the strengths and limitations of using cognitive behaviour therapy as a treatment of psychotic disorders.
The National Institute of Mental Health (NIMH, 2008) declared that psychotic disorders cost one hundred ninety three billion dollars annually due to loss of earning, diagnosis, treatment and other indirect costs. Cognitive behaviour therapies for psychotic disorders are an evidence informed management strategies that help patients and carers to make informed decisions for early intervention, prevention and recovery of psychotic disorder (NICE, 2009).
Numerous Meta analytical research suggested that cognitive behaviour therapy are effective in drug resistant symptoms and patient compliance to medication adherence (NICE, 2008; Wykes, Steel, Everitt &Tarrier, 2008). The systematic review of randomized trials revealed that cognitive behaviour therapy significantly reduced patients stay at the hospitals and prevent recurring hospitalization compared with other management therapies (NICE, 2009). However, the issue of whether cognitive behaviour therapy is as effective as claimed by the meta-analytical studies has been the subject for much debate. Research studies which employed proper control measures and methods of blinding reported that cognitive behaviour therapy is ineffective against relapse and reducing negative symptoms in patients suffering from schizophrenia (Scott et al., 2006; Lynch, Laws & McKenna, 2010).
Cognitive behaviour therapy is also indicated to be futile in befriending and interpersonal strategies (Sensky et al., 2000; Lewis et al., 2002). However, these arguments do not settle the issue in question. In fact, it is arguable that the strength of cognitive behaviour therapy for psychotic disorder lies in the evident based therapy that is derived from well validated theories, but the lack of validated research evidence limits the scope of therapy application and development of new therapy strategies for psychotic disorder.
Table of Contents
1. Critically discus the strengths and limitations of using Cognitive Behavioural Therapy (CBT) as treatment for psychotic disorders.
Objectives and Themes
This paper aims to critically evaluate the clinical efficacy, economic viability, and theoretical limitations of using Cognitive Behavioural Therapy (CBT) as a primary or adjunctive treatment for individuals suffering from psychotic disorders. The analysis centers on the tension between initial evidence-based support for CBT and more recent findings that question its effectiveness in routine clinical practice and long-term relapse prevention.
- Theoretical evolution and clinical techniques of CBT for psychosis.
- Critical analysis of efficacy vs. effectiveness in randomized controlled trials.
- Economic considerations and cost-effectiveness compared to standard care.
- Limitations of outcome measures and the need for personalized case formulations.
- Integration of new-wave cognitive therapies to address residual symptoms.
Excerpt from the Book
Critically discus the strengths and limitations of using Cognitive Behavioural Therapy (CBT) as treatment for psychotic disorders.
The National Institute of Mental Health (NIMH, 2008) declared that psychotic disorders cost one hundred ninety three billion dollars annually due to loss of earning, diagnosis, treatment and other indirect costs. The economic burden is also evident in UK and elsewhere around the world. In England, the cost for care and treatment for psychotic disorders is one hundred and five billion pounds a year (Cyhlarova, McCulloch, McGuffin, & Wykes, 2010). Although the pharmacological approach substantially reduces the economic burden of psychotic disorders, on the other spectrum, cost and benefits analysis of cognitive behaviour therapy indicates that greater access to the therapy would likely result in better treatment of psychotic disorders and reduction in costs of medical care and other economic burden (Myhr, G & Payne, K, 2006).
Cognitive behaviour therapies for psychotic disorders are an evidence informed management strategies that help patients and carers to make informed decisions for early intervention, prevention and recovery of psychotic disorder (NICE, 2009). Numerous Meta analytical research suggested that cognitive behaviour therapy are effective in drug resistant symptoms and patient compliance to medication adherence (NICE, 2008; Wykes, Steel, Everitt &Tarrier, 2008). The systematic review of randomized trials revealed that cognitive behaviour therapy significantly reduced patients stay at the hospitals and prevent recurring hospitalization compared with other management therapies (NICE, 2009).
Summary of Chapters
1. Critically discus the strengths and limitations of using Cognitive Behavioural Therapy (CBT) as treatment for psychotic disorders.: This chapter reviews the economic and clinical context of treating psychotic disorders, contrasting pharmacological approaches with the potential benefits and ongoing debates regarding the efficacy of CBT in reducing symptoms and hospitalization rates.
Keywords
Cognitive Behavioural Therapy, Psychotic Disorders, Schizophrenia, Mental Health Economics, Relapse Prevention, Medication Compliance, Evidence-based Practice, Clinical Efficacy, Symptom Management, Psychotherapy, Therapeutic Alliance, Social Ranking Model, New-wave Therapies, Treatment Outcomes.
Frequently Asked Questions
What is the primary focus of this paper?
The paper examines the effectiveness and limitations of Cognitive Behavioural Therapy (CBT) as an intervention for patients diagnosed with psychotic disorders.
What are the central themes discussed?
Key themes include the economic impact of psychosis, the clinical evidence for CBT in symptom reduction, the debate over its effectiveness in routine practice, and the comparison between CBT and standard treatment.
What is the core research objective?
The objective is to critically assess whether the widespread adoption of CBT for psychosis is justified by current research evidence or if its effectiveness is overstated in comparison to alternative therapies.
Which scientific methods are analyzed in this document?
The work analyzes findings from meta-analytical research, randomized controlled trials, and longitudinal cost-effectiveness studies within clinical psychiatric settings.
What content is covered in the main body?
The main body covers the history of CBT in psychosis, specific techniques such as Socratic questioning and formulation, the impact of therapeutic alliances, and the limitations of current diagnostic rating scales.
Which keywords characterize this work?
Relevant keywords include Cognitive Behavioural Therapy, Schizophrenia, Relapse Prevention, Clinical Efficacy, and Mental Health Economics.
How do 'new-wave' therapies differ from standard CBT?
New-wave therapies, such as Acceptance and Commitment Therapy (ACT), often shift the focus from changing negative thoughts to fostering mindfulness and acceptance, aiming to address symptoms that generic CBT struggles to treat.
Why is the economic evaluation of CBT significant?
Economic evaluation is critical because while CBT is often more expensive initially than "treatment as usual," it aims to reduce long-term costs by preventing relapses and minimizing time spent in hospitals.
- Quote paper
- Ms. Raja Sree R Subramaniam (Author), 2013, Strengths and Limitations of using Cognitive Behavioural Therapy (CBT) as Treatment for Psychotic Disorders, Munich, GRIN Verlag, https://www.grin.com/document/313308
